International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064

Downloads: 9 | Views: 41 | Weekly Hits: ⮙2 | Monthly Hits: ⮙2

Review Papers | Biotechnology | India | Volume 11 Issue 3, March 2022

Breast Cancer

Namisha [2]

Abstract: Breast cancer is the most common cancer in women in developed countries, and 12% of breast cancer is found in women aged 20-34. Survival of breast cancer has been greatly improved, and the potential side effects of late treatment and impact on quality of life have been significant. Young women make up a small percentage of patients with breast cancer, but they often have different problems and problems compared to older women, including questions about fertility, contraception and pregnancy. In addition, older women are more likely to have questions about the possible side effects of treatment and the risk of relapses or new circumstances. In addition, many will experience treatment-related symptoms and present a management challenge. Obstetricians and gynecologists often see these women immediately after initial diagnosis or adjuvant treatment and should be aware of current breast cancer treatment, options for increasingly at risk of genetic predisposition, prognosis for first-line breast cancer patients and how adjuvant. Formal treatment may affect reproductive function. The breast begins to develop during childbirth and undergoes major changes during puberty and adulthood. Breast cancer occurs when abnormal cell growth occurs within certain structures and types of cells within the breast. Although breast cancer is often referred to as a single disease, advancing techniques for analyzing cellular features identify different types of origins. A better understanding of the type of heterogeneity of breast cancer will be important in helping researchers improve the design and interpretation of risk studies, and may also influence prevention strategies.

Keywords: Lymphomas, oncologists, Nulliparity, locoregional tumor, BRCA1, BRCA2, Oophorectomy

Edition: Volume 11 Issue 3, March 2022,

Pages: 169 - 176

How to Download this Article?

Type Your Email Address below to Receive the Article PDF Link

Verification Code will appear in 2 Seconds ... Wait